Frontier Biotechnologies Inc. (SHA:688221)

Frontier Biotechnologies Statistics

Total Valuation

SHA:688221 has a market cap or net worth of CNY 5.82 billion. The enterprise value is 5.43 billion.

Market Cap	5.82B
Enterprise Value	5.43B

Important Dates

The last earnings date was Saturday, August 30, 2025.

Earnings Date	Aug 30, 2025
Ex-Dividend Date	n/a

Share Statistics

SHA:688221 has 374.58 million shares outstanding. The number of shares has increased by 0.35% in one year.

Current Share Class	374.58M
Shares Outstanding	374.58M
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+3.67%
Owned by Insiders (%)	16.08%
Owned by Institutions (%)	1.62%
Float	210.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	42.47
PB Ratio	5.58
P/TBV Ratio	6.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-39.25
EV / Sales	39.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-25.97

Financial Position

The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.32.

Current Ratio	2.88
Quick Ratio	2.65
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	-1.60
Interest Coverage	-25.45

Financial Efficiency

Return on equity (ROE) is -12.42% and return on invested capital (ROIC) is -10.43%.

Return on Equity (ROE)	-12.42%
Return on Assets (ROA)	-8.44%
Return on Invested Capital (ROIC)	-10.43%
Return on Capital Employed (ROCE)	-19.49%
Revenue Per Employee	261,559
Profits Per Employee	-263,886
Employee Count	302
Asset Turnover	0.07
Inventory Turnover	1.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +224.09% in the last 52 weeks. The beta is 0.90, so SHA:688221's price volatility has been similar to the market average.

Beta (5Y)	0.90
52-Week Price Change	+224.09%
50-Day Moving Average	18.69
200-Day Moving Average	11.92
Relative Strength Index (RSI)	41.96
Average Volume (20 Days)	23,788,241

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688221 had revenue of CNY 137.06 million and -138.28 million in losses. Loss per share was -0.37.

Revenue	137.06M
Gross Profit	41.16M
Operating Income	-251.29M
Pretax Income	-138.28M
Net Income	-138.28M
EBITDA	-239.18M
EBIT	-251.29M
Loss Per Share	-0.37

Balance Sheet

The company has 727.26 million in cash and 333.68 million in debt, giving a net cash position of 393.59 million or 1.05 per share.

Cash & Cash Equivalents	727.26M
Total Debt	333.68M
Net Cash	393.59M
Net Cash Per Share	1.05
Equity (Book Value)	1.04B
Book Value Per Share	2.79
Working Capital	703.17M

Cash Flow

In the last 12 months, operating cash flow was -181.55 million and capital expenditures -27.45 million, giving a free cash flow of -209.01 million.

Operating Cash Flow	-181.55M
Capital Expenditures	-27.45M
Free Cash Flow	-209.01M
FCF Per Share	-0.56

Margins

Gross margin is 30.03%, with operating and profit margins of -183.35% and -100.89%.

Gross Margin	30.03%
Operating Margin	-183.35%
Pretax Margin	-100.89%
Profit Margin	-100.89%
EBITDA Margin	-174.51%
EBIT Margin	-183.35%
FCF Margin	n/a

Dividends & Yields

SHA:688221 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.35%
Shareholder Yield	n/a
Earnings Yield	-2.38%
FCF Yield	-3.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHA:688221 has an Altman Z-Score of 1.24 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.24
Piotroski F-Score	2